Magenta Therapeutics, Inc.MGTANASDAQ
Loading
Year-over-year SG&A expense growth
5Y CAGR
+6.2%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 37.36% |
| 2024 | 0.00% |
| 2022 | -7.75% |
| 2021 | -0.57% |
| 2020 | 18.21% |
| 2019 | 27.59% |
| 2018 | 137.90% |
| 2017 | 124.56% |
| 2016 | 0.00% |